contract_awardAwarded Thursday, July 30, 2026Analyzed

MCKESSON CORPORATION: $24.7M Department of Justice Contract

Neutral

Summary

McKesson Corporation received a $24.7M delivery order from the Bureau of Prisons for non-controlled medication. This is a routine, small contract relative to McKesson's $309B revenue, with negligible financial impact. No related legislation or presidential actions directly affect this award.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.McKesson's $24.7M prison medication contract is negligible relative to its $309B revenue.
  • 2.No related legislation or executive actions directly impact this award.
  • 3.Investors should not expect any stock price movement from this routine contract.

Market Implications

The contract has no meaningful market implications. McKesson's stock is driven by broader healthcare trends, drug pricing, and distribution margins, not by small government delivery orders. No other tickers are affected.

Full Analysis

The contract award is a $24.7M delivery order to McKesson Corporation from the Department of Justice's Federal Prison System for non-controlled medication for the period October 1, 2025 through December 31, 2025, with performance through August 2026. McKesson is the direct recipient and a publicly traded company with FY2026 revenue of $309.0B. The contract represents only 0.008% of annual revenue, making it immaterial to McKesson's financial performance. No related bills from the provided list directly authorize or fund this specific contract; the bills cover topics like gambling, agriculture, privacy, and defense, none of which connect to prison medication procurement. Supply chain beneficiaries are not identifiable from this award alone, as McKesson likely sources generic pharmaceuticals from multiple manufacturers. Historically, similar small-value delivery orders for prison healthcare supplies have no discernible impact on McKesson's stock price. The contract is a routine operational renewal with no market-moving implications.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationJul 13, 2026

Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security

President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).

Exec OrderJun 25, 2026

Advancing Regenerative Agriculture and Strengthening American Farm Resilience

This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Contract Details

Recipient

MCKESSON CORPORATION

Award Amount

$24,731,493

Awarding Agency

Department of Justice

Sub-Agency

Federal Prison System / Bureau of Prisons

Contract Type

DELIVERY ORDER

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →